Intrust Bank Na Ligand Pharmaceuticals Inc Transaction History

Intrust Bank Na

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	SELL	$107.38 - $129.34 $246,437 - $296,835	-2,295 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$105.93 - $142.47 $22,669 - $30,488	-214 Reduced 8.53%	2,295 $289,000
Q4 2018 Feb 06, 2019	SELL	$128.36 - $272.13 $133,366 - $282,743	-1,039 Reduced 29.28%	2,509 $340,000
Q3 2018 Nov 09, 2018	BUY	$211.18 - $274.49 $4,012 - $5,215	19 Added 0.54%	3,548 $974,000
Q2 2018 Aug 08, 2018	BUY	$150.77 - $207.98 $24,726 - $34,108	164 Added 4.87%	3,529 $731,000

Q1 2018 May 03, 2018	BUY	$138.63 - $182.62 $56,145 - $73,961	405 Added 13.68%	3,365 $556,000
Q4 2017 Feb 08, 2018	BUY	$128.36 - $147.04 $51,857 - $59,404	404 Added 15.81%	2,960 $406,000
Q3 2017 Nov 06, 2017	BUY	$120.91 - $137.94 $309,045 - $352,574	2,556	2,556 $348,000

233

16.5M

77.9K

25K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.47B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Intrust Bank Na, based on Form 13F filings with the SEC.

Stay updated on Intrust Bank Na with notifications on news.